UCL Research Domains


Steering Group

The Cancer Research Domain's activities are overseen by a Steering Group composed of researchers from across UCL.


Professor Daniel HochhauserUCL Cancer Institute; UCLH BRC; CRUK Centre co-leadChemo-DNA interactions, GI cancer
Professor Alison LloydMRC Laboratory for Molecular Cell BiologyCell growth, tissue regeneration, nerve repair, tumour development
Professor Gary RoyleUCL Department of Medical Physics and Biomedical EngineeringImaging and sensor systems, RTx and proton therapy, cellular imaging


Professor Giuseppe BattagliaUCL ChemistrySynthesis, drug/gene carriers and delivery, diagnostics
Professor Mark EmbertonDean, UCL Faculty of Medical Sciences Prostate cancer
Professor Tariq EnverDirector, UCL Cancer InstituteLeukaemia, single cell analysis, stem cells
Dr Sahra GibbonUCL AnthropologyBRCA genetics, risk, inequities, public health
Dr Darren HargraveUCL Great Ormond Street Institute of Child HealthPaediatric neuro-oncology
Professor Jonathan LedermannUCL Cancer Institute; Director, CRUK Cancer Trials CentreCancer Trials and Gynaecological Cancers
Professor Paula LorgellyUCL Department of Applied Health ResearchEconomics of cancer
Professor Nick LuscombeUCL Department of Genetics, Evolution and Environment; Francis Crick Institute; eMedLabBioinformatics, gene expression
Professor Georgios LyratzopoulosUCL Institute of Epidemiology & HealthCancer epidemiology, behavioural science and health
Professor Mark LythgoeUCL Division of Medicine; Director of the Centre for Advanced Biomedical ImagingAdvanced imaging and tracking
Professor Emma MorrisUCL Division of Infection & Immunity; BRC; AHSCImmunotherapy, transduced T cells, WT1
Professor Andrew PomiankowskiUCL Department of Genetics, Evolution and EnvironmentGenetics, sexual reproduction, evolution
Dr Martin PuleUCL Cancer InstituteEngineered immune cell therapy, CAR T, commercial
Professor Rosalind RaineHead of UCL Department of Applied Health Research; Director of NIHR CLAHRC North ThamesCancer services, risk factors, screening
Professor Charlie SwantonUCL Cancer Institute; Francis Crick Institute; CRUK Chief ClinicianLung, heterogeneity, evolution
Professor Henning WalczakUCL Cancer Institute; CRUK Centre co-leadCell death, immunity, inflammation